SANUWAVE Health, Inc. announced it has entered into a second amendment to certain provisions of the two promissory notes dated August 1, 2005 between the Company and HealthTronics, Inc. with an aggregate outstanding principal balance of $5,372,743.  

The second amendment provides for the extension of the due date of the promissory notes to January 31, 2018. In connection with the second amendment, the Company issued to HealthTronics, Inc. an additional 1,890,000 Class K warrants to purchase shares of common stock, subject to anti-dilution protection.  The exercise price of these additional Class K warrants and the original 3,310,000 Class K warrants issued is $0.08. The warrants vested upon issuance and expire after ten years.

"We are pleased we were able to successfully further extend the terms of our promissory notes with HealthTronics, from whom we acquired SANUWAVE’s extensive patent and technology platform in 2005. As a result, we now have financial flexibility to finalize our submission to the FDA, pursue several of our strategic initiatives and growth strategies slated for the second half of 2016 and beyond," commented Kevin A. Richardson II, SANUWAVE’s Chairman of the board of directors.

For additional information about the Company, visit www.sanuwave.com.